Science & Education

Cannabis and Driving: DUI Laws, Impairment Science, and What You Need to Know

By RethinkTHC Research Team|17 min read|February 24, 2026

Science & Education

2x Crash Risk

THC slows reaction time, impairs lane tracking, and degrades divided attention, but a 2015 NHTSA study found cannabis alone at low THC levels was not significantly tied to crash risk after adjusting for alcohol.

Compton et al., JAMA, 2015

Compton et al., JAMA, 2015

Infographic showing cannabis roughly doubles crash risk with impaired reaction time and lane trackingView as image

You have probably heard someone say they drive better high. Maybe you have said it yourself. It feels true in the moment because cannabis changes how you perceive your own performance, not just your actual performance. But the science on weed DUI, driving impaired, and cannabis laws tells a more complicated and more important story than either "weed makes you a terrible driver" or "it is totally fine."

The truth sits in an uncomfortable middle. Cannabis does impair driving ability. The impairment is real, measurable, and potentially deadly. But the legal system we have built to deal with it is full of gaps, and the testing methods we rely on are fundamentally flawed. Understanding both sides of this equation matters whether you use cannabis, know someone who does, or simply share the road with people who might.

Key Takeaways

  • THC slows your reaction time, messes with your lane tracking, and impairs divided attention — the three skills you need most behind the wheel
  • A 2015 NHTSA-funded study in JAMA found that at low THC levels, cannabis alone was not significantly tied to crash risk after adjusting for alcohol and demographics — but impairment jumps substantially at higher doses
  • Weed DUI laws are all over the map: some states set a specific THC blood limit (often 5 ng/mL), some have zero-tolerance policies, and some have no THC-specific threshold at all
  • Blood THC levels do not predict impairment the way blood alcohol concentration does, which creates a real problem for law enforcement and the legal system
  • Most researchers say to wait at least 3 to 4 hours after smoking or vaping and 6 to 8 hours after edibles before driving — though individual variation is significant
  • The National Academies of Sciences said there is "insufficient evidence to establish a blood THC concentration that can reliably indicate impairment," which is why current cannabis DUI testing is fundamentally flawed

What THC Actually Does to Your Driving Ability

Science & Education

THC vs Alcohol: Driving Skill Impairment Comparison

Driving SkillTHCAlcoholCombined
Reaction TimeSlowedSlowedSeverely slowed
Lane Tracking (SDLP)Impaired (~0.05% BAC equivalent)Severely impairedDangerous
Divided AttentionSignificantly impairedSignificantly impairedDangerous
Risk AssessmentSome self-awareness retainedOverconfidence, risk-takingSelf-awareness lost
Speed ControlTend to drive slowerTend to drive fasterUnpredictable

"I drive better high" is wrong. Cannabis users rated their driving as better while high. Objective simulator data showed worse lane tracking, slower reaction time, and impaired divided attention. THC alters how your brain evaluates its own performance.

Cannabis DUI Law Categories
Per Se Limit5 ng/mL THC in blood
CO, WA, MT, OH
Zero ToleranceAny THC or metabolites
AZ, GA, DE, IN, IA
Effect-BasedMust prove impairment
CA, NY, others

National Academies 2017: "insufficient evidence to establish a blood THC concentration that can reliably indicate impairment"

Hartman (2015, Clinical Chemistry) • Ramaekers (2006)THC vs Alcohol: Driving Skill Impairment Comparison

Your ability to drive safely depends on a handful of cognitive and motor skills working together in real time: reaction speed, the ability to track your lane position, divided attention (monitoring your mirrors, speed, and traffic signals simultaneously), and accurate judgment of time and distance.

THC disrupts all of them.

A landmark 2015 study led by Rebecca Hartman and published in Clinical Chemistry recruited experienced cannabis users and had them smoke either a placebo or active THC cigarette, then drive a standardized course. The researchers measured standard deviation of lateral position (SDLP), which is basically how much your car weaves within and outside of your lane. THC produced a statistically significant increase in lane weaving, with effects similar to driving at a blood alcohol concentration (BAC) of about 0.05%, which is just under the legal limit in most states.

That same research team found that THC slowed reaction time, reduced the accuracy of divided attention tasks, and impaired tracking performance. These deficits were dose-dependent, meaning the more THC in the system, the worse the performance.

The Divided Attention Problem

Here is where it gets particularly relevant to real-world driving. Cannabis has a well-documented effect on divided attention, which is your ability to handle multiple tasks at once. In a lab, this might mean tracking a moving object on a screen while responding to an audio cue. On the road, it means watching the car ahead of you while checking your mirrors while noticing a pedestrian stepping off the curb while adjusting your speed for a curve.

Research by Ramaekers and colleagues has reviewed driving simulation and on-road studies and concluded that cannabis consistently impairs tasks that require dividing attention between multiple information streams.[1] Simple, well-practiced tasks like maintaining a steady speed on an empty highway showed less impairment. Complex, unpredictable situations showed much more.

This is why the subjective experience of "driving fine" can be so misleading. If your evening drive home follows the same route it always does and nothing unexpected happens, you might genuinely feel no different. But the margin you have for reacting to something unexpected, a child running into the street, a car slamming its brakes, a deer appearing in your lane, is narrower than you think.

How Cannabis Impairment Differs from Alcohol Impairment

People often compare weed DUI to drunk driving, but the two impairments are qualitatively different in ways that matter both scientifically and legally.

Alcohol impairs nearly every aspect of driving. It reduces reaction time, causes lane weaving, impairs judgment, increases risk-taking behavior, and produces overconfidence. Drunk drivers tend to drive faster and take more risks because alcohol specifically targets the brain's ability to assess danger.

Cannabis produces a more selective impairment. It slows reaction time and impairs divided attention, but interestingly, research consistently shows that cannabis users tend to compensate for their impairment in ways that alcohol users do not. A frequently cited 2009 review in the American Journal of Addiction found that stoned drivers tend to drive slower, increase following distance, and take fewer risks. They appear to be aware, at least partially, that they are impaired.

This compensation effect is real, but it has limits. It works on simple, predictable driving tasks. It breaks down when the unexpected happens, which is exactly when you need your full cognitive capacity. The compensation also varies wildly depending on dose, tolerance, and whether alcohol is involved. When cannabis and alcohol are combined, the impairment is significantly greater than either substance alone, a point that the safer cannabis use guidelines emphasize repeatedly.

The "I Drive Better High" Myth

This belief is so common it deserves its own section. When researchers have tested it directly, the results are consistent: people who believe they drive better while high are wrong.

A study published in Drug and Alcohol Dependence asked regular cannabis users to rate their own driving performance after consuming THC. They consistently rated their performance as better than their sober baseline. The objective measurements from the driving simulator told the opposite story. Their lane tracking was worse, their reaction time was slower, and their divided attention was impaired.

This gap between perceived and actual performance is a hallmark of cannabis intoxication. THC alters how your brain evaluates its own output. You feel more focused, more present, more in the zone. The data says otherwise. This is the same perception gap that shows up in other areas of cannabis use, as the research on cannabis perception versus evidence documents across multiple domains.

The legal framework for cannabis-impaired driving in the United States is a patchwork with no federal standard. Laws fall into roughly three categories.

Per Se THC Limits

Some states have set specific blood THC thresholds above which a driver is legally considered impaired, regardless of observable behavior. The most common limit is 5 nanograms of THC per milliliter of blood (5 ng/mL). Colorado, Washington, Montana, and Ohio use this threshold. Nevada's limit is 2 ng/mL.

The problem with per se limits is scientific, and it is significant. Unlike blood alcohol concentration, which correlates relatively well with impairment across individuals, blood THC levels are a poor predictor of how impaired someone actually is.

Zero-Tolerance States

Several states, including Arizona, Georgia, Delaware, Indiana, Iowa, and others, operate under zero-tolerance laws. In these states, any detectable amount of THC or its metabolites in your blood can result in a DUI charge. This creates a particular problem for regular users, because THC metabolites can remain detectable in blood for days or even weeks after last use, long after any impairment has worn off. The science on how long THC stays in your system makes clear just how disconnected detection windows are from actual impairment windows.

Effect-Based States

Some states have no THC-specific limit and instead require officers to demonstrate actual impairment through observable behavior, field sobriety tests, and sometimes the testimony of a Drug Recognition Expert (DRE). These states include California, New York, and several others in the Northeast.

The Detection Problem: Why Blood THC Is Not Like BAC

This is the core scientific issue that makes cannabis DUI law so much more complicated than alcohol DUI law, and it is the reason the legal landscape is such a mess.

With alcohol, there is a reasonably linear, well-studied relationship between blood alcohol concentration and degree of impairment. A BAC of 0.08% corresponds to a predictable and measurable level of cognitive and motor impairment in the vast majority of people. The science supports the legal threshold.

With THC, no such clean relationship exists. Here is why.

THC is lipophilic, meaning it dissolves in fat rather than water. After you inhale cannabis, THC blood levels spike rapidly within minutes, then crash within 1 to 2 hours as the compound redistributes from blood into fat tissue. But the cognitive effects can persist for 3 to 4 hours or longer. This means a person could have relatively low blood THC but still be significantly impaired.

Conversely, a daily cannabis user might have measurable THC in their blood at all times due to slow release from fat stores, without being impaired at all. A 2013 study in Clinical Chemistry found that chronic daily users had detectable blood THC levels (above 1 ng/mL) even after a full week of supervised abstinence. If that person were pulled over and tested in a zero-tolerance state, they could face DUI charges while being completely sober.

A National Academies of Sciences report in 2017 stated plainly that there is "insufficient evidence to establish a blood THC concentration that can reliably indicate impairment." This is not a minor caveat. It is a fundamental limitation of the entire testing framework. The rise in THC potency over time has only made this more complicated, as higher-dose products produce more variable blood levels and more unpredictable impairment timelines.

DUID Testing: How Cannabis DUI Is Detected

When an officer suspects cannabis-impaired driving, the process typically follows a sequence.

Step 1: Initial stop and observation. The officer notes driving behavior (weaving, speed inconsistency, delayed responses) and any signs during the stop (odor of cannabis, bloodshot eyes, slow speech).

Step 2: Standardized Field Sobriety Tests (SFSTs). These are the same tests used for alcohol: the horizontal gaze nystagmus test, the walk-and-turn, and the one-leg stand. The problem is that these tests were designed and validated for alcohol impairment. Cannabis does not produce the same eye movement patterns that alcohol does, making the HGN test particularly unreliable for weed DUI.

Step 3: Drug Recognition Expert (DRE) evaluation. A DRE-trained officer performs a more extensive 12-step protocol that includes pulse checks, pupil dilation measurements, and additional coordination tests. DRE evaluations are more thorough but still subjective and have been challenged in court for reliability.

Step 4: Chemical testing. Blood draws (and in some jurisdictions, oral fluid tests) measure THC concentration. As discussed above, the scientific limitations of these measurements are substantial.

Some states and companies are developing roadside oral fluid testing devices that measure THC in saliva. These are faster and less invasive than blood draws, but they share the same fundamental limitation: detecting the presence of THC is not the same as measuring impairment.

A weed DUI carries real consequences that vary by state but generally include fines ranging from $1,000 to $10,000 or more for repeat offenses. A first offense typically means license suspension for 90 days to one year. Some states require mandatory substance abuse evaluation or treatment programs. Jail time is possible, particularly for repeat offenses or if an accident was involved. A DUI conviction goes on your criminal record and can affect employment, housing, insurance rates, and professional licensing.

In states where cannabis is legal, a DUI conviction can still result in all of these penalties. Legal cannabis means legal to possess and use, not legal to drive under the influence. This distinction catches some people off guard.

How Long Should You Wait Before Driving?

The honest answer is that there is no perfect number because individual variation in metabolism, tolerance, dose, and product type makes a single recommendation imprecise. But researchers and public health agencies have offered guidance.

After inhaling (smoking or vaping): Most studies suggest peak impairment occurs within the first 30 to 60 minutes and diminishes substantially by 3 to 4 hours. The Canadian Centre on Substance Use and Addiction recommends waiting at least 3 to 4 hours after inhalation, and longer if you used a high-potency product or are an infrequent user.

After edibles: Because oral THC is absorbed more slowly and produces a longer-lasting effect, the wait time is significantly longer. Peak effects from edibles can occur 2 to 3 hours after consumption and may last 6 to 8 hours or more. Driving within 8 hours of consuming a significant edible dose is risky, especially if you have less experience with how your body processes oral THC.

After high-dose or concentrate use: If you are using products in the 50% THC and above range, the standard wait times may not be sufficient. Higher doses produce longer impairment windows. There is no substitute for honest self-assessment, and the research shows we are bad at self-assessment when THC is involved.

The safest approach: If you know you need to drive, do not use cannabis beforehand. Plan ahead. Use a rideshare, designate a sober driver, or wait until you are home for the night. This is the same harm reduction logic that applies to alcohol, and it works.

When to Seek Professional Help

If you find yourself regularly driving after using cannabis despite knowing the risks, or if you feel unable to avoid using before situations where driving is required, that pattern may signal a deeper issue with your relationship to cannabis.

You do not need to figure it out alone. SAMHSA's National Helpline at 1-800-662-4357 provides free, confidential, 24/7 referrals to treatment and support services. The call is free, it is available in English and Spanish, and they can connect you with local resources.

The Bottom Line

Cannabis impairs driving. That is not a scare tactic or a political position. It is what the research consistently shows. THC slows your reaction time, degrades your divided attention, and disrupts your lane tracking while simultaneously making you think you are doing fine.

At the same time, the legal and testing systems we have built to deal with cannabis-impaired driving are imperfect. Blood THC does not work like BAC. Zero-tolerance laws can penalize sober people. Per se limits pick an arbitrary number that the science does not fully support. These are real problems that deserve real solutions, and they are being actively researched.

What you can control is your own behavior. Know your state's laws. Understand that how impaired you feel is not a reliable measure of how impaired you are. Build in wait times that are longer than you think you need. And treat the decision to drive after using cannabis with the same seriousness you would give to driving after drinking. Your reaction time, your passengers, and the other people on the road are worth that extra planning.

The Bottom Line

THC impairs the three driving skills most critical for safety: reaction time, lane tracking (SDLP), and divided attention. Hartman 2015 (Clinical Chemistry) found THC produced lane weaving comparable to BAC ~0.05%. Ramaekers' review confirmed cannabis consistently impairs divided attention tasks — simple, practiced driving tasks show less impairment while complex, unpredictable situations show much more, explaining why subjective "driving fine" experience is misleading. Key difference from alcohol: cannabis users tend to compensate (drive slower, increase following distance, take fewer risks) per 2009 American Journal of Addiction review, but compensation breaks down during unexpected events and when alcohol is combined. "I drive better high" myth: Drug and Alcohol Dependence study showed cannabis users rated their own driving as better while THC objectively worsened lane tracking, reaction time, and divided attention — same perception gap documented across cannabis use domains. Legal landscape: per se states (5 ng/mL in CO, WA, MT, OH; 2 ng/mL in NV); zero-tolerance states (any THC/metabolites = DUI, problematic because metabolites detectable days/weeks after use); effect-based states (require demonstrated impairment). Core scientific problem: blood THC does not correlate with impairment like BAC does — THC is lipophilic (spikes then crashes in blood while effects persist), chronic users maintain detectable levels while sober. National Academies 2017: "insufficient evidence to establish a blood THC concentration that can reliably indicate impairment." Wait time guidance: 3-4 hours after inhalation, 6-8 hours after edibles, longer for high-potency/concentrates. CBD alone does not impair driving (Arkell 2020, JAMA). DUI consequences: $1,000-$10,000+ fines, 90-day to 1-year license suspension, possible jail, criminal record.

Frequently Asked Questions

Sources & References

  1. 1RTHC-00242·Ramaekers, J G et al. (2006). Study Identifies THC Blood Levels of 2-5 ng/ml as the Threshold Where Driving Impairment Begins.” Drug and alcohol dependence.Study breakdown →PubMed →
  2. 2RTHC-02393·Arkell, Thomas R et al. (2020). THC impaired driving for about 4 hours but CBD did not, in on-road driving test.” JAMA.Study breakdown →PubMed →

Research Behind This Article

Showing the 8 most relevant studies from our research database.

Strong EvidenceMeta-Analysis

Does Illicit Drug Use Increase Stroke Risk? A Systematic review, Meta-Analyses and Mendelian Randomization analysis.

Ritson, Megan · 2026

Meta-analysis of 32 studies (>100 million participants) found cannabis associated with 37% higher stroke risk (OR 1.37), cocaine with 96% higher risk (OR 1.96), and amphetamines with 122% higher risk (OR 2.22).

Strong EvidenceMeta-Analysis

Cannabis use and atrial arrhythmias: A systematic review and meta-analysis of large populational studies.

Chye, David M · 2025

Cannabis associated with 71% increased atrial arrhythmia risk (OR 1.71, 95% CI 1.1-2.6); risk higher with concomitant drug use (OR 1.91) and in cannabis-legal countries (OR 1.93); 12.5% of cannabis users had AA vs 2.7% of controls..

Strong EvidenceMeta-Analysis

Cannabis consumption and risk of asthma: a systematic review and meta-analysis.

Malvi, Ajay · 2025

The pooled odds ratio for asthma diagnosis among cannabis users was 1.31 (95% CI: 1.19-1.44), indicating 31% greater odds compared to non-users.

Strong EvidenceMeta-Analysis

Adverse events caused by cannabinoids in middle aged and older adults for all indications: a meta-analysis of incidence rate difference.

Velayudhan, Latha · 2024

THC alone and THC:CBD combinations significantly increased all-cause and treatment-related adverse events compared to controls.

Strong EvidenceMeta-Analysis

Cannabis and adverse cardiovascular events: A systematic review and meta-analysis of observational studies

Theerasuwipakorn, Nonthikorn · 2023

As cannabis legalization expands globally, the cardiovascular safety question becomes increasingly urgent.

Strong EvidenceMeta-Analysis

A large-scale genome-wide association study meta-analysis of cannabis use disorder.

Johnson, Emma C · 2020

This GWAS meta-analysis identified 22 genome-wide significant loci associated with cannabis use disorder, with SNP-based heritability estimated at 11%.

Strong EvidenceMeta-Analysis

Genome-wide association meta-analysis of age at first cannabis use.

Minică, Camelia C · 2018

Researchers conducted the largest genome-wide association study of age at first cannabis use to date. Twin analysis (8,055 twins from three cohorts) estimated heritability at 38% (95% CI 19-60%).

Strong EvidenceMeta-Analysis

GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.

Pasman, Joëlle A · 2018

In the largest GWAS of lifetime cannabis use to date, researchers analyzed 184,765 individuals and identified eight genome-wide significant SNPs in six genomic regions. All measured genetic variants combined explained 11% of the variance in cannabis use. Gene-based tests revealed 35 significant genes in 16 regions.